The European Parliament approved a report on a draft directive on protection of biotechnology inventions, suggesting 60 amendments intended to overcome a host of ethical and commercial issues. The directive is intended to harmonize patent policies throughout the European Union and to ensure that biotechnology innovations are accorded the same level of protection in Europe as they receive in the U.S. and Japan.

The 370 to 113 vote